Philippe Yaiche
Inventor
Stats
- 43 US patents issued
- 48 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 43 US Patents Issued
- 48 US Applications Filed
- 129 Total Citation Count
- Jan 28, 2013 Most Recent Filing
- Aug 31, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
MITSUBISHI PHARMA CORPORATION | 1
3 5 1 9 2 14 3 | 2001
2002 2003 2004 2005 2006 2007 2008 |
Tanabe Pharma Corporation | 1
| 2009
|
SANOFI-AVENTIS | 1
2 | 2005
2010 |
MITSUBISHI TANABE PHARMA CORPORATION | 1
1 2 2 2 11 22 1 | 2001
2003 2006 2007 2008 2009 2010 2011 |
MITSUBISHI ELECTRIC CORPORATION | 1
| 2010
|
SANOFI | 2
3 6 1 8 4 16 5 13 27 1 1 | 2001
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2013 |
Inventor Addresses
Address | Duration |
---|---|
FR-93260 Les Lilas, FR | Jun 02, 05 - Jun 02, 05 |
Les Lias, FR | Nov 18, 08 - Nov 18, 08 |
Les Lilas, FR | Mar 04, 04 - Dec 03, 13 |
Paris, FR | Feb 05, 09 - Jul 07, 15 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 7 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 47 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 29 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
9073914 | 2015 | Substituted alkyl pyrimidin-4-one derivatives | 0 |
9073915 | 2015 | Substituted pyrimidone derivatives | 0 |
8889702 | 2014 | Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof | 0 |
8865738 | 2014 | 5-membered heterocyclic compound cyclopenta[C]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof | 1 |
8716289 | 2014 | Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.